LEPTAVOID-H
LEPTAVOID-H
Authorised
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo, strain 204, Inactivated
Product identification
Medicine name:
LEPTAVOID-H
Active substance:
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo, strain 204, Inactivated
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serogroup Sejroe, serovar Hardjo, strain 204, Inactivated9.00/Organisms2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Burgwedel Biotech GmbH
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 1156 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 2/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 2/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 2/11/2022
How useful was this page?:
